Omega-3 lowers inflammation, blood pressure in obese adults
Cardiovascular disease, or CVD, is a leading cause of death worldwide, and diet strongly influences risk. The American Heart Association recommends reducing saturated fat and increasing polyunsaturated fatty acids, or PUFA, intake, which may cut CVD risk by up to 30%. PUFAs include omega-3 and omega-6, but their direct effects on CVD-related inflammation have not been well compared.
In a recent study, published in the Journal of Lipid Research, Elise Grytten of Haukeland University Hospital and colleagues compared omega-3, or fish oil, and omega-6, or safflower oil, supplements on CVD risk markers. Participants were overweight adults aged 30–70 with abdominal obesity. They received either omega-3 supplements (rich in eicosapentaenoic, or EPA, and docosahexaenoic, or DHA, acids) or omega-6 supplements (rich in linoleic acid) in randomized seven-week sequences. Omega-3 supplements reduced proinflammatory chemokines such as CCL5 and CCL4, suggesting these anti-inflammatory effects could lower CVD risk. Transcriptomic analysis showed overlapping changes in 75 genes across both groups. However, omega-6s’ anti-inflammatory benefits depended on sufficient omega-3 intake. Furthermore, omega-3 lowered blood pressure in participants without hypertension, while omega-6 increased it. Overall, the findings suggest that high-quality omega-3– and omega-6–rich oils may lower the risk of abdominal obesity and cardiometabolic disease. Also, supplementation of omega-6, in contrast to omega-6, appeared to increase adipose inflammation, with unknown clinical relevance.
Despite limitations — including possible carryover effects, unequal supplement doses and small sample size — the authors believe their findings provide new insight into how PUFAs affect adipose inflammation. In the future, they plan to study how omega-6 alters linoleic acid–derived metabolites.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Cholesterol as a novel biomarker for Fragile X syndrome
Researchers in Quebec identified lower levels of a brain cholesterol metabolite, 24-hydroxycholesterol, in patients with fragile X syndrome, a finding that could provide a simple blood-based biomarker for understanding and managing the condition.
How lipid metabolism shapes sperm development
Researchers at Hokkaido University identify the enzyme behind a key lipid in sperm development. The findings reveal how seminolipids shape sperm formation and may inform future diagnostics and treatments for male infertility.
Mass spec method captures proteins in native membranes
Yale scientists developed a mass spec protocol that keeps proteins in their native environment, detects intact protein complexes and tracks drug binding, offering a clearer view of membrane biology.
Laser-assisted cryoEM method preserves protein structure
University of Wisconsin–Madison researchers devised a method that prevents protein compaction during cryoEM prep, restoring natural structure for mass spec studies. The approach could expand high-resolution imaging to more complex protein systems.
Method sharpens proteome-wide view of structural changes
Researchers developed a method that improves limited proteolysis coupled with mass spectrometry, separating true changes from abundance or splicing effects.
Discoveries made possible by DNA
The discovery of DNA’s double helix revealed how genetic information is stored, copied and expressed. Revisit that breakthrough and traces how it laid the foundation for modern molecular biology, genomics and biotechnology.